Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

513 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Difference in the relation between urinary albumin excretion and carotid intima-media thickness in nondiabetic and type 2 diabetic subjects.
Diercks GF, Stroes ES, Van Boven AJ, Van Roon AM, Hillege HL, De Jong PE, Smit AJ, Gans RO, Crijns HJ, Rabelink TJ, Van Gilst WH. Diercks GF, et al. Among authors: van gilst wh, van roon am, van boven aj. Diabetes Care. 2002 May;25(5):936-7. doi: 10.2337/diacare.25.5.936. Diabetes Care. 2002. PMID: 11978696 No abstract available.
Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects.
Diercks GF, Stroes ES, van Boven AJ, van Roon AM, Hillege HL, de Jong PE, Smit AJ, Gans RO, Crijns HJ, Rabelink TJ, van Gilst WH. Diercks GF, et al. Among authors: van gilst wh, van roon am, van boven aj. Atherosclerosis. 2002 Jul;163(1):121-6. doi: 10.1016/s0021-9150(01)00748-1. Atherosclerosis. 2002. PMID: 12048129
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.
Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE; Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Hillege HL, et al. Among authors: van gilst wh, van veldhuisen dj. Circulation. 2002 Oct 1;106(14):1777-82. doi: 10.1161/01.cir.0000031732.78052.81. Circulation. 2002. PMID: 12356629
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, de Zeeuw D, de Jong PE, van Veldhuisen DJ, van Gilst WH; Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators. Asselbergs FW, et al. Among authors: van gilst wh, van boven aj, van veldhuisen dj. Circulation. 2004 Nov 2;110(18):2809-16. doi: 10.1161/01.CIR.0000146378.65439.7A. Epub 2004 Oct 18. Circulation. 2004. PMID: 15492322 Clinical Trial.
513 results